The abstract is read at the publisher; the summary is JClub's.
WSTF/BAZ1B directly phosphorylates AKT1 at tyrosine 417 (Y417), promoting PI3K-dependent AKT1 activation and suppressing tumor growth when WSTF is genetically ablated.
- Why it matters: WSTF is known as a tyrosine kinase for histone H2AX, but its broader cancer-relevant substrates and how it supports oncogenic signaling were unclear.
- What they did: The study mapped WSTF-dependent AKT1 Y417 phosphorylation, showed EYA3 removes it, and tested effects on PI3K-driven AKT1 membrane recruitment and activation in cell and xenograft models.
- The result: Removing WSTF reduced AKT pathway activity and inhibited tumor growth in both cell-based and xenograft models, supporting WSTF as a non-canonical AKT activator and a drug target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.